07 Aug Xinya Lu
Posted at 15:25h
in
Bio
Xinya joined HQC in January 2013. Since then, he has served as a research analyst on drug safety and effectiveness projects. Prior to joining HQC, Xinya worked as an SAS analyst with the College of Pharmacy and Nutrition at the University of Saskatchewan. Xinya received a Master’s degree in public health from the University of Saskatchewan and a PhD in microbiology from the Chinese Academy of Science in China.
CNODES Projects
Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson’s Disease
Analyst, Saskatchewan- Analyst
Comparison of pregnancy outcomes of patients treated with ondansetron vs alternative antiemetic medications in a multinational, population-based cohort
Analyst, SaskatchewanUtilization and adverse outcomes of fluconazole during pregnancy
Analyst, SaskatchewanPrescription ranitidine use and population exposure in 6 Canadian provinces, 1996 to 2019: a serial cross-sectional analysis
Analyst, SaskatchewanOff-label postpartum use of domperidone in Canada: a multidatabase cohort study
Analyst, SaskatchewanChanges in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
Analyst, Saskatchewan